Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma

• Κύριοι συγγραφείς: Joy M. Davis (Συγγραφέας), Tullia Rushton (Συγγραφέας), Felicity Nsiah (Συγγραφέας), Rebecca L. Stone (Συγγραφέας), Anna L. Beavis (Συγγραφέας), Stéphanie L. Gaillard (Συγγραφέας), Alice Dobi (Συγγραφέας), Amanda N. Fader (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2024-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Dedifferentiated endometrial carcinoma is a rare, highly aggressive subtype of endometrial cancer associated with poor survival outcomes. Current guidelines recommend treatment of advanced-stage disease with surgical staging or cytoreduction and platinum/taxane-based chemotherapy. Despite these appr...